Net Deals Web Search

  1. Ads

    related to: alcon pharmaceuticals fort worth jobs

Search results

  1. ALC - Alcon Inc.

    Yahoo Finance

    88.23-1.20 (-1.34%)

    at Tue, May 28, 2024, 4:00PM EDT - U.S. markets open in 2 hours 30 minutes

    Pre Mkt 88.05 -0.18 (-0.20%)

    Delayed Quote

    • Ask Price 88.10
    • Bid Price 88.14
    • P/E 42.42
    • 52 Wk. High 91.08
    • 52 Wk. Low 69.44
    • Mkt. Cap 43.67B
  2. Results From The WOW.Com Content Network
  3. Alcon Laboratories is considering a major $100M expansion of ...

    www.aol.com/alcon-laboratories-considering-major...

    Alcon, which started in Fort Worth and has grown to become the world’s largest eye care device company, is looking to invest an estimated $100 million to build a 250,000-square-foot ...

  4. Alcon - Wikipedia

    en.wikipedia.org/wiki/Alcon

    Alcon Inc. (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people.

  5. Akorn - Wikipedia

    en.wikipedia.org/wiki/Akorn

    Akorn Operating Company LLC ( Akorn Inc. prior to its bankruptcy) was an American generic pharmaceuticals manufacturer based in Lake Forest, Illinois. The company dealt in developing, manufacturing and marketing of generic and prescription drugs as well as animal and consumer health products. [1] It was a component of the NASDAQ Biotechnology ...

  6. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    Novartis. / 47.5744252; 7.5764914. Pharmaceutical drugs, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health ( list...) Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical ...

  7. Novartis Completes Purchase of Alcon Majority Stake ... - AOL

    www.aol.com/news/2010-08-26-novartis-alcon-buy...

    The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.

  8. Novartis chairman says Alcon worth $20 billion -$30 ... - AOL

    www.aol.com/news/novartis-chairman-says-alcon...

    The chairman of Swiss drugmaker Novartis (NOVN.S) expects Alcon to be valued at between $20 billion (15.14 billion pounds) and $30 billion when the opthalmic devices unit is spun off to ...